Randomized Controlled Trials Evaluating Artificial Intelligence in Cardiovascular Care: A Systematic Review
Authors' conclusion
This review highlights AI's potential to enhance cardiovascular care through improved early detection, diagnostic accuracy, and resource efficiency.
Study context
- Population
- Randomized controlled trials (RCTs) of artificial intelligence (AI) in cardiology; MEDLINE, Web of Science, Cochrane Library from inception to November 202411 RCTs
- Comparison
- AI vs traditional methods in cardiovascular care
- Outcome
- Patient-important metrics
Methodological detailsPRISMA
- PRISMA
Pooled result
As reported in the abstract
Studies reporting improvements in clinical events
5
45.5%
Studies showing enhanced diagnostic accuracy and early detection
6
54.5%
Studies demonstrating improved resource utilization
3
27.3%
Further pooled results
Trial characteristics
- Multicenter trials
- 81.2%
- Studies conducted between 2021 and 2024
Original publication
Randomized Controlled Trials Evaluating Artificial Intelligence in Cardiovascular Care: A Systematic Review. JACC Adv. Published 24 September 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →